159 related articles for article (PubMed ID: 24726876)
1. Recruitment of phosphatase PP2A by RACK1 adaptor protein deactivates transcription factor IRF3 and limits type I interferon signaling.
Long L; Deng Y; Yao F; Guan D; Feng Y; Jiang H; Li X; Hu P; Lu X; Wang H; Li J; Gao X; Xie D
Immunity; 2014 Apr; 40(4):515-29. PubMed ID: 24726876
[TBL] [Abstract][Full Text] [Related]
2. Protein phosphatase PP1 negatively regulates the Toll-like receptor- and RIG-I-like receptor-triggered production of type I interferon by inhibiting IRF3 phosphorylation at serines 396 and 385 in macrophage.
Gu M; Zhang T; lin W; Liu Z; Lai R; Xia D; Huang H; Wang X
Cell Signal; 2014 Dec; 26(12):2930-9. PubMed ID: 25239187
[TBL] [Abstract][Full Text] [Related]
3. Meet the terminator: The phosphatase PP2A puts brakes on IRF-3 activation.
Chattopadhyay S; Sen GC
Mol Cell; 2014 Apr; 54(2):210-1. PubMed ID: 24766884
[TBL] [Abstract][Full Text] [Related]
4. Scaffolding adaptor protein Gab1 is required for TLR3/4- and RIG-I-mediated production of proinflammatory cytokines and type I IFN in macrophages.
Zheng Y; An H; Yao M; Hou J; Yu Y; Feng G; Cao X
J Immunol; 2010 Jun; 184(11):6447-56. PubMed ID: 20435932
[TBL] [Abstract][Full Text] [Related]
5. Peroxisome proliferator-activated receptor gamma negatively regulates IFN-beta production in Toll-like receptor (TLR) 3- and TLR4-stimulated macrophages by preventing interferon regulatory factor 3 binding to the IFN-beta promoter.
Zhao W; Wang L; Zhang M; Wang P; Zhang L; Yuan C; Qi J; Qiao Y; Kuo PC; Gao C
J Biol Chem; 2011 Feb; 286(7):5519-28. PubMed ID: 21148557
[TBL] [Abstract][Full Text] [Related]
6. Interferon-inducible cytoplasmic lncLrrc55-AS promotes antiviral innate responses by strengthening IRF3 phosphorylation.
Zhou Y; Li M; Xue Y; Li Z; Wen W; Liu X; Ma Y; Zhang L; Shen Z; Cao X
Cell Res; 2019 Aug; 29(8):641-654. PubMed ID: 31213650
[TBL] [Abstract][Full Text] [Related]
7. RNA helicase DDX5 suppresses IFN-I antiviral innate immune response by interacting with PP2A-Cβ to deactivate IRF3.
Zan J; Xu R; Tang X; Lu M; Xie S; Cai J; Huang Z; Zhang J
Exp Cell Res; 2020 Nov; 396(2):112332. PubMed ID: 33065113
[TBL] [Abstract][Full Text] [Related]
8. Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral response.
Oganesyan G; Saha SK; Guo B; He JQ; Shahangian A; Zarnegar B; Perry A; Cheng G
Nature; 2006 Jan; 439(7073):208-11. PubMed ID: 16306936
[TBL] [Abstract][Full Text] [Related]
9. A type I interferon autocrine-paracrine loop is involved in Toll-like receptor-induced interleukin-12p70 secretion by dendritic cells.
Gautier G; Humbert M; Deauvieau F; Scuiller M; Hiscott J; Bates EE; Trinchieri G; Caux C; Garrone P
J Exp Med; 2005 May; 201(9):1435-46. PubMed ID: 15851485
[TBL] [Abstract][Full Text] [Related]
10. KAT8 selectively inhibits antiviral immunity by acetylating IRF3.
Huai W; Liu X; Wang C; Zhang Y; Chen X; Chen X; Xu S; Thomas T; Li N; Cao X
J Exp Med; 2019 Apr; 216(4):772-785. PubMed ID: 30842237
[TBL] [Abstract][Full Text] [Related]
11. A Novel Function of F-Box Protein FBXO17 in Negative Regulation of Type I IFN Signaling by Recruiting PP2A for IFN Regulatory Factor 3 Deactivation.
Peng D; Wang Z; Huang A; Zhao Y; Qin FX
J Immunol; 2017 Jan; 198(2):808-819. PubMed ID: 27956528
[TBL] [Abstract][Full Text] [Related]
12. The adaptor protein MITA links virus-sensing receptors to IRF3 transcription factor activation.
Zhong B; Yang Y; Li S; Wang YY; Li Y; Diao F; Lei C; He X; Zhang L; Tien P; Shu HB
Immunity; 2008 Oct; 29(4):538-50. PubMed ID: 18818105
[TBL] [Abstract][Full Text] [Related]
13. TBK1-targeted suppression of TRIF-dependent signaling pathway of toll-like receptor 3 by auranofin.
Park SJ; Lee AN; Youn HS
Arch Pharm Res; 2010 Jun; 33(6):939-45. PubMed ID: 20607500
[TBL] [Abstract][Full Text] [Related]
14. LY294002 inhibits TLR3/4-mediated IFN-β production via inhibition of IRF3 activation with a PI3K-independent mechanism.
Zhao W; Qi J; Wang L; Zhang M; Wang P; Gao C
FEBS Lett; 2012 Mar; 586(6):705-10. PubMed ID: 22285490
[TBL] [Abstract][Full Text] [Related]
15. RACK1 T50 Phosphorylation by AMPK Potentiates Its Binding with IRF3/7 and Inhibition of Type 1 IFN Production.
Qin C; Niu C; Shen Z; Zhang Y; Liu G; Hou C; Dong J; Zhao M; Cheng Q; Yang X; Zhang J
J Immunol; 2021 Sep; 207(5):1411-1418. PubMed ID: 34348973
[TBL] [Abstract][Full Text] [Related]
16. Elimination of GPR146-mediated antiviral function through IRF3/HES1-signalling pathway.
Huang H; Zhang N; Xiong Q; Chen R; Zhang C; Wang N; Wang L; Ren H; Liu M; Qian M; Du B
Immunology; 2017 Sep; 152(1):102-114. PubMed ID: 28464285
[TBL] [Abstract][Full Text] [Related]
17. Membrane Perturbation-Associated Ca2+ Signaling and Incoming Genome Sensing Are Required for the Host Response to Low-Level Enveloped Virus Particle Entry.
Hare DN; Collins SE; Mukherjee S; Loo YM; Gale M; Janssen LJ; Mossman KL
J Virol; 2015 Dec; 90(6):3018-27. PubMed ID: 26719279
[TBL] [Abstract][Full Text] [Related]
18. Targeting 7-Dehydrocholesterol Reductase Integrates Cholesterol Metabolism and IRF3 Activation to Eliminate Infection.
Xiao J; Li W; Zheng X; Qi L; Wang H; Zhang C; Wan X; Zheng Y; Zhong R; Zhou X; Lu Y; Li Z; Qiu Y; Liu C; Zhang F; Zhang Y; Xu X; Yang Z; Chen H; Zhai Q; Wei B; Wang H
Immunity; 2020 Jan; 52(1):109-122.e6. PubMed ID: 31882361
[TBL] [Abstract][Full Text] [Related]
19. Virus infection triggers SUMOylation of IRF3 and IRF7, leading to the negative regulation of type I interferon gene expression.
Kubota T; Matsuoka M; Chang TH; Tailor P; Sasaki T; Tashiro M; Kato A; Ozato K
J Biol Chem; 2008 Sep; 283(37):25660-25670. PubMed ID: 18635538
[TBL] [Abstract][Full Text] [Related]
20. IRF3-binding lncRNA-ISIR strengthens interferon production in viral infection and autoinflammation.
Xu J; Wang P; Li Z; Li Z; Han D; Wen M; Zhao Q; Zhang L; Ma Y; Liu W; Jiang M; Zhang X; Cao X
Cell Rep; 2021 Nov; 37(5):109926. PubMed ID: 34731629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
